GPs’ management strategies for patients with insomnia: a survey and qualitative interview study
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients frequently experience sleep problems and present to primary care. However, information is limited regarding the management strategies that GPs employ. AIM: To gain an understanding of current GP management strategies for insomnia. DESIGN AND SETTING: A postal questionnaire survey and qualitative interviews with GPs in the south of England. METHOD: A postal survey of 296 GPs and qualitative interviews were carried out with 23 of the GPs. RESULTS: The survey response rate was 56% (166/296). GPs look for signs of depression and anxiety in patients and if present treat these first. 'Sleep hygiene' advice is provided by 88% (147/166) of GPs but often seems insufficient and they feel under pressure to prescribe. Benzodiazepines and Z drugs are prescribed, often reluctantly, for short periods, because of known problems with dependence and tolerance. Many GPs prescribe low-dose amitriptyline for insomnia although it is not licensed for this indication. For insomnia 95% (157/166) of survey responders 'ever prescribe' amitriptyline, with 31% (52/166) stating they do so commonly. Most GPs perceived amitriptyline to be effective and a longer-term option for those with ongoing sleep problems. GPs report a lack of knowledge and confidence in the provision and use of psychological therapies, such as cognitive behavioural therapy (CBT), in the management of insomnia. CONCLUSION: GPs often find 'sleep hygiene' advice is insufficient for managing insomnia and report frequently prescribing medication, including amitriptyline (off licence), which is often based on perceived patient pressure for a prescription. Patients are rarely offered psychological therapies such as CBT for insomnia, despite evidence suggesting its potential effectiveness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In a survey of British general practitioners, many reported pressures in prescribing BZD to patients and a lack of adequate knowledge on alternative psychological treatment for insomnia [41].”
From Benzodiazepines: Uses, Dangers, and Clinical Considerations (2021) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interpreting Qualitative Data Methods for Analysing Talk, Text and Interaction
Kleinsasser, R. C., & Silverman, D. (1997) · The Modern Language Journal · doi:10.2307/329190 · Cited by 6,866
Silverman, D. (2024) · SAGE Publications Ltd eBooks · doi:10.4135/9781036233358 · Cited by 3,553
Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.8.1172 · Cited by 1,098
Use of sleep hygiene in the treatment of insomnia
Stepanski, E. J., & Wyatt, J. K. (2003) · Sleep Medicine Reviews · doi:10.1053/smrv.2001.0246 · Cited by 733
Prevalence, burden, and treatment of insomnia in primary care
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.10.1417 · Cited by 694
Wilson, S., Nutt, D., Alford, C., Argyropoulos, S., Baldwin, D., Bateson, A., Britton, T., Crowe, C., Dijk, D.-J., Espie, C., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110379307 · Cited by 634
Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S. L. (2012) · Sleep · doi:10.5665/sleep.1872 · Cited by 550
Antidepressants and their effect on sleep
Mayers, A. G., & Baldwin, D. S. (2005) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.726 · Cited by 323
Self-citationCognitive behavioural interventions for sleep problems in adults aged 60+
Montgomery, P., & Dennis, J. A. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003161 · Cited by 231
Ringdahl, E. N., Pereira, S. L., & Delzell, J. E. (2004) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.17.3.212 · Cited by 125
Cited by
Benzodiazepine Use in the United States
Olfson, M., King, M., & Schoenbaum, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1763 · Cited by 786
Koffel, E., Bramoweth, A. D., & Ulmer, C. S. (2018) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4390-1 · Cited by 391
Benzodiazepines: Uses, Dangers, and Clinical Considerations
Edinoff, A. N., Nix, C. A., Hollier, J., Sagrera, C. E., Delacroix, B. M., Abubakar, T., Cornett, E. M., Kaye, A. M., & Kaye, A. D. (2021) · Neurology International · doi:10.3390/neurolint13040059 · Cited by 340
“In a survey of British general practitioners, many reported pressures in prescribing BZD to patients and a lack of adequate knowledge on alternative psychological treatment for insomnia [41].”
BackgroundSleep hygiene education as a treatment of insomnia: a systematic review and meta-analysis
Chung, K.-F., Lee, C.-T., Yeung, W.-F., Chan, M.-S., Chung, E. W.-Y., & Lin, W.-L. (2018) · Family Practice · doi:10.1093/fampra/cmx122 · Cited by 313
“General practitioners seldom conduct CBT-I or refer patients with insomnia for psychological treatment (14,15).”
Baglioni, C., Altena, E., Bjorvatn, B., Blom, K., Bothelius, K., Devoto, A., Espie, C. A., Frase, L., Gavriloff, D., Tuuliki, H., et al. (2020) · Journal of Sleep Research · doi:10.1111/jsr.12967 · Cited by 259
“Despite this, available data indicate that GPs rarely prescribe or are able to offer CBT-I to patients with insomnia (e.g., Everitt et al., 2014; Koffel et al., 2018).”
BackgroundAntidepressants for insomnia in adults
Everitt, H., Baldwin, D. S., Stuart, B., Lipinska, G., Mayers, A., Malizia, A. L., Manson, C. C., & Wilson, S. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010753.pub2 · Cited by 198
Trends in the Concomitant Prescribing of Opioids and Benzodiazepines, 2002−2014
Hwang, C. S., Kang, E. M., Kornegay, C. J., Staffa, J. A., Jones, C. M., & McAninch, J. K. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.02.014 · Cited by 190
“The reason for the increases in benzodiazepine prescribing, both overall and in the setting of opioid use, is not entirely clear, but may involve growing prescriber comfort with benzodiazepines or beliefs that other pharmacologic or non-pharmacologic treatments are ineffective for conditions such as insomnia, anxiety,…”
BackgroundFord, A. C., Wright-Hughes, A., Alderson, S. L., Ow, P.-L., Ridd, M. J., Foy, R., Bianco, G., Bishop, F. L., Chaddock, M., Cook, H., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01523-4 · Cited by 146
“15 Amitriptyline has shown promise in two previous small trials in IBS, 27,28 is an established, inexpensive drug, which general practitioners prescribe commonly for other conditions, 19 and has a well characterised safety profile.”
Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review
Pollmann, A. S., Murphy, A. L., Bergman, J. C., & Gardner, D. M. (2015) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-015-0019-8 · Cited by 114
“The perceived or real inaccessibility to alternative treatment modalities may further encourage the renewal of benzodiazepine and Z-drug prescriptions in favor of initiating other interventions that are perceived as less effective [21].”
BackgroundNi, X., Shergis, J. L., Guo, X., Zhang, A. L., Li, Y., Lu, C., & Xue, C. C. (2015) · Sleep Medicine · doi:10.1016/j.sleep.2015.08.012 · Cited by 87
“However, the risks and side effects associated with BZDs, such as daytime drowsiness and drug dependency, have been noted in both research and clinical practice [9,121–123].”
BackgroundCheung, J. M. Y., Jarrin, D. C., Ballot, O., Bharwani, A. A., & Morin, C. M. (2019) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2018.11.001 · Cited by 84
Kyle, S. D., Siriwardena, A. N., Espie, C. A., Yang, Y., Petrou, S., Ogburn, E., Begum, N., Maurer, L. F., Robinson, B., Gardner, C., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00683-9 · Cited by 79
Van der Zweerde, T., Lancee, J., Slottje, P., Bosmans, J. E., Van Someren, E. J. W., & van Straten, A. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000505600 · Cited by 76
Insomnia disorder: clinical and research challenges for the 21st century
Ferini‐Strambi, L., Auer, R., Bjorvatn, B., Castronovo, V., Franco, O. H., Gabutti, L., Galbiati, A., Hajak, G., Khatami, R., Kitajima, T., et al. (2021) · European Journal of Neurology · doi:10.1111/ene.14784 · Cited by 88
Torres-Bondia, F., de Batlle, J., Galván, L., Buti, M., Barbé, F., & Piñol-Ripoll, G. (2020) · BMC Public Health · doi:10.1186/s12889-020-08984-z · Cited by 69
Cheung, J. M. Y., Bartlett, D. J., Armour, C. L., Laba, T.-L., & Saini, B. (2018) · Behavioral Sleep Medicine · doi:10.1080/15402002.2016.1163702 · Cited by 64
“…limited availability and accessibility of effective treatment options through primary care (i.e., pharmacotherapy or sleep hygiene [monotherapy]), which subsequently also limits the number of options available for the patient or provider to choose from (Cheung et al., 2013; Everitt et al., 2014).”
BackgroundHigh prevalence of insomnia and hypnotic use in patients visiting their general practitioner
Bjorvatn, B., Meland, E., Flo, E., & Mildestvedt, T. (2017) · Family Practice · doi:10.1093/fampra/cmw107 · Cited by 64
Sweetman, A., Putland, S., Lack, L., McEvoy, R. D., Adams, R., Grunstein, R., Stocks, N., Kaambwa, B., Van Ryswyk, E., Gordon, C., et al. (2021) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2020.101404 · Cited by 62
Sleep Disturbance and Chronic Widespread Pain
McBeth, J., Wilkie, R., Bedson, J., Chew-Graham, C. A., & Lacey, R. J. (2015) · Current Rheumatology Reports · doi:10.1007/s11926-014-0469-9 · Cited by 70
Maurer, L. F., Espie, C. A., Omlin, X., Reid, M. J., Sharman, R., Gavriloff, D., Emsley, R., & Kyle, S. D. (2020) · Sleep · doi:10.1093/sleep/zsaa096 · Cited by 54
Begum, M., González‐Chica, D. A., Bernardo, C., Woods, A., & Stocks, N. P. (2021) · British Journal of General Practice · doi:10.3399/bjgp.2021.0054 · Cited by 63
“…sought by patients and prescribed by GPs, such as reducing pack sizes where possible, increasing the availability of non-pharmaceutical interventions for insomnia management, 51 and introducing real-time prescription monitoring to identify patients who visit multiple doctors for prescriptions.”
Off-label uses of drugs for depression
Skånland, S. S., & Cieślar‐Pobuda, A. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172732 · Cited by 63
Maire, M., Linder, S., Dvořák, C., Merlo, C., Essig, S., Tal, K., Giovane, C. D., Syrogiannouli, L., Duss, S. B., Heinzer, R. C., et al. (2020) · Journal of Sleep Research · doi:10.1111/jsr.13121 · Cited by 59
“PCPs also often feel pressured to prescribe hypnotics (Linder et al., unpublished data, Everitt et al., 2014; Hughes et al., 2016).”
BackgroundHaycock, J., Grivell, N., Redman, A., Saini, B., Vakulin, A., Lack, L. C., Lovato, N., Sweetman, A., Zwar, N. A., Stocks, N. P., et al. (2021) · BMC Family Practice · doi:10.1186/s12875-021-01510-z · Cited by 61
Screening for insomnia in primary care: using a two-item version of the Sleep Condition Indicator
Luik, A. I., Machado, P. F., Siriwardena, N., & Espie, C. A. (2019) · British Journal of General Practice · doi:10.3399/bjgp19x701045 · Cited by 49
Moloney, M. (2016) · Sociology of Health & Illness · doi:10.1111/1467-9566.12485 · Cited by 72
Comorbid Insomnia and Sleep Apnea
Sweetman, A., Lack, L. C., Crawford, M., & Wallace, D. M. (2022) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2022.07.006 · Cited by 55
Espie, C. A., & Henry, A. L. (2023) · Journal of Sleep Research · doi:10.1111/jsr.14025 · Cited by 46
“In practice, therefore, most patients receive second-line care; namely sedative hypnotics, off-label medication, or sleep hygiene (Everitt et al., 2014).”
Backgroundvan der Zweerde, T., Lancee, J., Slottje, P., Bosmans, J. E., Someren, E. J. W. V., Reynolds, C. F., Cuijpers, P. J., & van Straten, A. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0783-z · Cited by 45
“A possible reason is that GPs generally have insufficient time or knowledge to provide the CBT-I themselves [33].”
BackgroundSweetman, A., Lovato, N., Micic, G., Scott, H., Bickley, K., Haycock, J., Harris, J., Gradisar, M., & Lack, L. (2020) · Sleep Medicine · doi:10.1016/j.sleep.2020.08.023 · Cited by 39
Co‐occurring depression and insomnia in Australian primary care: recent scientific evidence
Sweetman, A., Lack, L. C., Ryswyk, E. V., Vakulin, A., Reed, R. L., Battersby, M., Lovato, N., & Adams, R. (2021) · The Medical Journal of Australia · doi:10.5694/mja2.51200 · Cited by 41
Referral Practices for Cognitive Behavioral Therapy for Insomnia: A Survey Study
Conroy, D. A., & Ebben, M. R. (2015) · Behavioural Neurology · doi:10.1155/2015/819402 · Cited by 38
“This is consistent with a similar large survey study of 296 general practitioners in England, which revealed that sleep hygiene advice is provided by 88% of GPs [20].”
ResultChronic hypnotic use at 10 years—does the brand matter?
Schonmann, Y., Goren, O., Bareket, R., Comaneshter, D. S., Cohen, A. D., & Vinker, S. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-2531-4 · Cited by 60
Delivering Cognitive Behavioral Therapy for Insomnia in the Real World
Buenaver, L. F., Townsend, D., & Ong, J. C. (2019) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2019.01.008 · Cited by 35
Landolt, S., Rosemann, T., Blozik, E., Brüngger, B., & Huber, C. A. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s290104 · Cited by 34
“Furthermore, general practitioners reported insufficient knowledge and confidence in the provision and use of alternative psychological therapies in the management of insomnia.(51) Due to changes in pharmacokinetics and pharmacodynamics resulting from older age, the risk of benzodiazepine side effects increases in the…”
BackgroundInsomnia Management in the Australian Primary Care Setting
Sake, F., WONG, K. K. H., Bartlett, D. J., & Saini, B. (2017) · Behavioral Sleep Medicine · doi:10.1080/15402002.2016.1266491 · Cited by 38
“● Pharmacological treatment ● Nonpharmacological treatments Studies show that a majority of insomnia cases are managed by prescribing medication in general practice settings (Charles et al., 2009; Everitt et al., 2014).”
BackgroundStott, R. B., Pimm, J., Emsley, R., Miller, C. B., & Espie, C. A. (2021) · Behaviour Research and Therapy · doi:10.1016/j.brat.2021.103922 · Cited by 37
Svensson, S. A., Hedenrud, T., & Wallerstedt, S. M. (2019) · BMC Family Practice · doi:10.1186/s12875-018-0885-4 · Cited by 31
Internet-Delivered Cognitive Behavioral Therapy for Insomnia
van der Zweerde, T., Lancee, J., Luik, A. I., & van Straten, A. (2020) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2020.02.001 · Cited by 33
Baka, A., van der Zweerde, T., Lancee, J., Bosmans, J. E., & van Straten, A. (2021) · Behavioral Sleep Medicine · doi:10.1080/15402002.2021.1901708 · Cited by 31
“supporting the effectiveness of CBT-I, general practitioners (GPs) primarily tend to prescribe medication (Everitt et al., 2014).”
BackgroundSampson, C., Bell, E., Cole, A., Miller, C. B., Marriott, T., Williams, M., & Rose, J. (2021) · BJGP Open · doi:10.3399/bjgpo.2021.0146 · Cited by 33
“This is due in part to a shortage of trained providers(5) and a lack of treatment awareness.(2,6) dCBTI offers a potential solution.”
BackgroundInfluentialPeople with insomnia: experiences with sedative hypnotics and risk perception
Cheung, J. M. Y., Bartlett, D. J., Armour, C. L., Ellis, J. G., & Saini, B. (2015) · Health Expectations · doi:10.1111/hex.12388 · Cited by 31
Patient Preferences for Managing Insomnia: A Discrete Choice Experiment
Cheung, J. M. Y., Bartlett, D. J., Armour, C. L., Saini, B., & Laba, T. (2018) · Patient · doi:10.1007/s40271-018-0303-y · Cited by 26
“Despite limited efficacy, sleep hygiene is frequently advised in primary care practice [45, 46].”
BackgroundCognitive Behavioral Therapies for Insomnia and Hypnotic Medications
Cheung, J. M. Y., Ji, X., & Morin, C. M. (2019) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2019.01.006 · Cited by 28
Flaxer, J. M., Heyer, A., & Francois, D. (2020) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2020.10.011 · Cited by 23
Implementation of a digital cognitive behavioral therapy for insomnia pathway in primary care
Sweetman, A., Knieriemen, A., Hoon, E. A., Frank, O., Stocks, N. P., Natsky, A. N., Kaambwa, B., Vakulin, A., Lovato, N., Adams, R., et al. (2021) · Contemporary Clinical Trials · doi:10.1016/j.cct.2021.106484 · Cited by 24
Treatment of sleep disturbance in older adults
Reynolds, A. C., & Adams, R. (2019) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr.1565 · Cited by 26
Kaldo, V., Bothelius, K., Blom, K., Lindhé, M., Larsson, M., Karimi, K., Melder, S., Bondestam, V., Ulfsparre, C., Sternbrink, K., et al. (2019) · Journal of Sleep Research · doi:10.1111/jsr.12881 · Cited by 20
“Still, the majority of insomnia patients receive drug treatment, partly because access to CBT‐i is limited (Everitt et al., 2014).”
BackgroundTang, Y. W., Teoh, S. L., Yeo, J. H. H., Ngim, C. F., Lai, N. M., Durrant, S. J., & Lee, S. W. H. (2021) · Behavioral Sleep Medicine · doi:10.1080/15402002.2021.1915787 · Cited by 24
“However, CBT-I mostly still needs recommendation or prescription from GPs, who have been reluctant to embrace such therapies when treating insomnia (Everitt et al., 2014), and patient knowledge and beliefs about cognitive therapy also continue to operate as a significant barrier to the wider…”
BackgroundOff‐label low dose amitriptyline for insomnia disorder: Patient‐reported outcomes
Bakker, M. H., Hugtenburg, J. G., Smits, M. G., van der Horst, H. E., & Slottje, P. (2022) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5561 · Cited by 19
Cho, H. J., Kremer, S., & Young, J. (2021) · Current Sleep Medicine Reports · doi:10.1007/s40675-021-00220-3 · Cited by 16
Internet-Delivered Cognitive Behavioral Therapy for Insomnia
van der Zweerde, T., Lancee, J., Luik, A. I., & van Straten, A. (2019) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2019.04.002 · Cited by 16
A game-based learning approach to sleep hygiene education: a pilot investigation
Seaver, C., Bowers, C. A., Beidel, D. C., Holt, L., & Ramakrishnan, S. (2024) · Frontiers in Digital Health · doi:10.3389/fdgth.2024.1334840 · Cited by 13
“One survey (18) revealed that although 97% of general practitioners utilized SHE as a management tool for their patients, they often perceived SHE alone to be ineffective.”
BackgroundTreating insomnia in Swiss primary care practices: A survey study based on case vignettes
Linder, S., Duss, S. B., Dvořák, C., Merlo, C., Essig, S., Tal, K., Giovane, C. D., Syrogiannouli, L., Heinzer, R. C., Nissen, C., et al. (2020) · Journal of Sleep Research · doi:10.1111/jsr.13169 · Cited by 15
“…data collection in Swiss primary care practices revealed that half of patients with chronic insomnia in Swiss primary care still use BZD or BZRA for sleep problems (Maire et al., 2020), perhaps because patients are already dependent on them or pressure PCPs to prescribe (Everitt et al., 2014).”
BackgroundInfluentialEffects of Antidepressants on Sleep in Post-traumatic Stress Disorder: An Overview of Reviews
Lappas, A. S., Polyzopoulou, Z. A., Christodoulou, G. N., Bozikas, V., & Samara, M. T. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230801144328 · Cited by 12
Kyle, S. D., Madigan, C., Begum, N., Abel, L., Armstrong, S., Aveyard, P., Bower, P., Ogburn, E., Siriwardena, A., Yu, L.-M., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-036248 · Cited by 12
Pchelina, P. V., Poluektov, M. G., Berger, T., Krieger, T., Duss, S. B., & Bassetti, C. L. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00838 · Cited by 13
Bakker, M. H., Hugtenburg, J. G., van Straten, A., van der Horst, H. E., & Slottje, P. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-047142 · Cited by 12
Seifert, J., Maier, H. B., Führmann, F., Bleich, S., Stübner, S., Sieberer, M. G., Bernegger, X., Greil, W., Schüle, C., Toto, S., et al. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02504-6 · Cited by 13
“TCAs were only rarely used as monotherapy for the treatment of MDD, suggesting that TCAs were primarily exploited for their sedative properties (Everitt et al. 2014).”
MethodHollsten, I., Foldbo, B. M., Andersen, M. K. K., & Nexøe, J. (2020) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813432.2020.1753382 · Cited by 11
“However, studies have shown promising results for Internet-delivered [30] and group based [31] CBT-I, which could be potential ways to make non-pharmacological interventions for insomnia more applicable in a clinical setting.”
BackgroundInfluentialCheung, J. M. Y., Jarrin, D. C., Beaulieu‐Bonneau, S., Ivers, H., Morin, G., & Morin, C. M. (2021) · SLEEP · doi:10.1093/sleep/zsab141 · Cited by 10
Over-the-counter products for insomnia in adults: A scoping review of randomised controlled trials
Salame, A., Mathew, S., Bhanu, C., Bazo‐Alvarez, J. C., Bhamra, S. K., Heinrich, M., Walters, K. R., & Frost, R. (2025) · Sleep Medicine · doi:10.1016/j.sleep.2025.02.027 · Cited by 11
Lin, M., Hsiao, P.-R., & Hsu, H. (2022) · Healthcare · doi:10.3390/healthcare10030559 · Cited by 11
Swierzbiolek, B., Oldenhof, E., Byrne, J. E. M., & Staiger, P. K. (2024) · British Journal of General Practice · doi:10.3399/bjgp.2023.0310 · Cited by 11
Meredith, S., Frawley, J., Sibbritt, D. W., & Adams, J. (2020) · Sleep Science and Practice · doi:10.1186/s41606-019-0039-1 · Cited by 12
“These circumstances are reflected in the wider research evaluating perceived efficacy of treatments for sleeping disturbances such as ID by both individuals with sleep disturbances and those treating them (Everitt et al. 2014; Sivertsen et al. 2010).”
BackgroundGammoh, O., Alqudah, A. M., Qnais, E. Y., & Alotaibi, B. S. (2024) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2024.102685 · Cited by 9
“Effective insomnia management strategies involve non-medicated approaches such as sleep hygiene and others (Everitt et al., 2014).”
BackgroundTelephone-Guided Sleep Restriction for Insomnia: A Randomized Sleep Diary-Controlled Trial
Looman, M. I., Blanken, T. F., Schoenmakers, T. M., Reesen, J. E., Effting, M., Linnebank, F. E., van Straten, A., Kamphuis, J. H., & Lancee, J. (2025) · Psychotherapy and Psychosomatics · doi:10.1159/000545138 · Cited by 9
“Instead of CBT-I, patients often receive more readily available but less effective treatment options such as sleep medication or basic sleep hygiene education [5, 9, 10].”
Driot, D., Ouhayoun, S., Perinelli, F., Grézy-Chabardès, C., Birebent, J., Bismuth, M., & Dupouy, J. (2019) · Therapies · doi:10.1016/j.therap.2019.03.004 · Cited by 10
Mapping the illness trajectories of insomnia: a biographical disruption?
Cheung, J. M. Y., Saini, B., Bartlett, D. J., Laba, T., & Mason, P. H. (2016) · Sociology of Health & Illness · doi:10.1111/1467-9566.12525 · Cited by 11
Pchelina, P. V., Poluektov, M. G., Krieger, T., Duss, S. B., & Berger, T. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1301489 · Cited by 8
“Although CBT-I is highly effective, there is limited access to specialized clinicians (12 – 14).”
BackgroundBakker, M. H., Hugtenburg, J. G., Bet, P. M., Twisk, J. W. R., van der Horst, H. E., & Slottje, P. (2025) · British Journal of General Practice · doi:10.3399/bjgp.2024.0173 · Cited by 13
Stapel, B., Alvarenga, M. E., & Kahl, K. G. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1490585 · Cited by 8
“TCAs that are frequently used for insomnia treatment albeit in sub-therapeutic doses for treatment of depression (195, 199).”
Kyle, S. D., Bower, P., Yu, L., Siriwardena, A. N., Yang, Y., Petrou, S., Ogburn, E., Begum, N., Maurer, L., Robinson, B., et al. (2024) · Health Technology Assessment · doi:10.3310/rjyt4275 · Cited by 15
Wright-Hughes, A. M., Ford, A. C., Alderson, S. L., Ow, P. L., Ridd, M. J., Foy, R., Bishop, F. L., Chaddock, M., Cook, H., Cooper, D., et al. (2024) · Health Technology Assessment · doi:10.3310/bfcr7986 · Cited by 12
Sleep hygiene and the prevention of chronic insomnia
Ellis, J. G., & Allen, S. F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815373-4.00011-3 · Cited by 14
Polanka, B. M., Kundu, S., So‐Armah, K., Freiberg, M. S., Gupta, S. K., Zapolski, T. C. B., Hirsh, A. T., Bedimo, R., Budoff, M. J., Butt, A. A., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246073 · Cited by 8
“Antidepressant medication use was included, as these medications are commonly prescribed for sleep disturbance [38,39] and have been associated with systemic inflammation among PLWH [40].”
BackgroundStokes, E. A., Stott, R. B., Henry, A. L., Espie, C. A., & Miller, C. B. (2022) · BJGP Open · doi:10.3399/bjgpo.2022.0090 · Cited by 6
“Results appear to be the first to demonstrate statistically significant gains to QALYs with an automated dCBT intervention compared with a sleep hygiene control, the most common intervention used in general practice for insomnia management in the UK.(14,15) Results may also be useful as they allow researchers to model…”
Basheti, M. M., Tran, M., WONG, K. K. H., Gordon, C. J., Grunstein, R. R., & Saini, B. (2021) · Behavioral Sleep Medicine · doi:10.1080/15402002.2021.1975718 · Cited by 8
“Given the significant “noise” about the need to deprescribe benzodiazepines, many prescribers worldwide have switched to using off-label antidepressants and antipsychotics to counter insomnia (Everitt et al., 2014; Lai et al., 2011; Thompson et al., 2016).”
BackgroundSedative-, Hypnotic-, or Anxiolytic-Related Disorders
Dumas, E. (2021) · Psychiatry update · doi:10.1007/978-3-030-86430-9_8 · Cited by 7
Lee, J.-E., Jung, I. C., Lee, S.-Y., Lim, J.-H., Kim, B.-K., & Cho, E. (2022) · Healthcare · doi:10.3390/healthcare10112157 · Cited by 6
“However, in the real clinical setting, CBT-I has been underutilized owing to a lack of clinician training and its time-intensive nature [29].”
BackgroundPrather, A. A., Krystal, A. D., Emsley, R., Carl, J. R., Ball, T. M., Tarnai, K., Aguilera, A., Espie, C. A., & Henry, A. L. (2025) · JMIR Mental Health · doi:10.2196/84323 · Cited by 10
“In practice, insomnia is typically managed using pharmacotherapy [21-23], namely Food and Drug Administration (FDA)-approved medications (eg, zolpidem) or medications prescribed off-label (eg, trazodone), all of which can cause harmful side effects and are associated with dependency.”
Insomnia management in Dutch general practice: a routine care database study
Bakker, M. H., Oldejans, N. A., Hugtenburg, J. G., van der Horst, H. E., & Slottje, P. (2023) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813432.2023.2237073 · Cited by 7
“In two studies, however, some GPs reported that they did not offer non-pharmacological interventions and mainly prescribed sleep medication because they considered nonpharmacological interventions ineffective as patients had usually tried numerous self-help methods before consulting them [25,29].”
Xin, Q., Paudel, D., An, K., Ye, Y., Zheng, S., Chen, L., Zhang, B., & Yin, H. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.940741 · Cited by 7
Pchelina, P. V., Duss, S. B., Bernasconi, C., Berger, T., Krieger, T., Bassetti, C. L., & Urech, A. (2023) · Diagnostics · doi:10.3390/diagnostics13040781 · Cited by 7
Benzodiazepines and z-drugs - between treatment effectiveness and the risk of addiction
Cabaj, J., Bargieł, J., & Soroka, E. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.46.01.032 · Cited by 7
“While relaxation techniques are generally considered safe, they may not work for everyone and may require regular practice to be effective [34].”
BackgroundAttitudes and Difficulties Associated with Benzodiazepine Discontinuation
Takeshima, M., Aoki, Y., Ie, K., Katsumoto, E., Tsuru, E., Tsuboi, T., Inada, K., Kise, M., Watanabe, K., Mishima, K., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192315990 · Cited by 7
Markaryan, M., Labie, C., Verschueren, S., Assche, D. V., Nijs, J., Mairesse, O., Malfliet, A., de Vlam, K., Runge, N., Caeyers, N., et al. (2025) · Brazilian Journal of Physical Therapy · doi:10.1016/j.bjpt.2025.101243 · Cited by 5
“In accordance with previous studies, 79,80 participants noted that sleep is rarely a primary focus for patients, general practitioners, and physical therapists, as pain often takes precedence.”
Komatsu, M., Takeshima, M., Yoshizawa, K., Ogasawara, M., Kudo, M., Miyakoshi, E., Itoh, Y., Shibata, N., Ayabe, N., & Mishima, K. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1471457 · Cited by 6
Zheng, Y., Qin, Y., Lyu, Y., Li, L., Ya, C., & Yao, Z. (2021) · Medicine · doi:10.1097/md.0000000000028046 · Cited by 4
“However, previous studies have reported that insomnia is mainly treated by medication or sleep hygiene education in primary healthcare institutions.([11,12]) To change the status quo, some researchers have achieved success with the development of the brief behavioral therapy for insomnia (BBT-I) model([13,14]) or othe…”
BackgroundTakeshima, M., Sakurai, H., Inada, K., Aoki, Y., Ie, K., Kise, M., Yoshida, E., Matsui, K., Utsumi, T., Shimura, A., et al. (2024) · BMC Family Practice · doi:10.1186/s12875-024-02449-7 · Cited by 6
“Despite physicians understanding these risks [18, 24], BzRA continues to be prescribed for long-term use worldwide [25–27].”
BackgroundResultInfluentialBarnes, G. L., Lawrence, V. C., Khondoker, M. R., Stewart, R. J., & Brown, J. S. L. (2017) · Behavioral Sleep Medicine · doi:10.1080/15402002.2017.1301942 · Cited by 9
“General practitioners often regard sleep hygiene advice as insufficient (Everitt et al., 2014), yet patients commonly report wanting to know more about sleep and behavioral strategies to address their problems (Andrews, Coviello, Hurley, Rose, & Redeker, 2013).”
BackgroundCheung, J. M. Y., Ritterband, L. M., Chen, S., Ivers, H., & Morin, C. M. (2025) · Journal of Sleep Research · doi:10.1111/jsr.70127 · Cited by 4
Xu, Z., & Anderson, K. N. (2019) · The Cognitive Behaviour Therapist · doi:10.1017/s1754470x19000242 · Cited by 5
“In the UK, GPs generally have insufficient time or knowledge to be able to provide the CBTi themselves (Everitt et al., 2014), and tend to treat insomnia pharmacologically.”
BackgroundCBT‐I Protocols for Insomnia Co‐morbid with Somatic Disorders
Bjorvatn, B. (2022) · Wiley eBooks · doi:10.1002/9781119891192.ch14 · Cited by 2
Sýkorová, M., Nolte, E., Martineau, F., Miller, M. A., Eriksson, S., Smith, I. E., & Strongman, H. (2025) · medRxiv · doi:10.1101/2025.01.20.25320835 · Cited by 4
Le, P. H., Le, L. K., Perez, J. K., Rajaratnam, S. M. W., & Mihalopoulos, C. (2025) · BJPsych Open · doi:10.1192/bjo.2025.10077 · Cited by 4
“10,30,31 There is evidence that insomnia is likely to impair response to depression treatment and worsen the quality of life of those experiencing depression.”
Ishtiak‐Ahmed, K., Jensen‐Dahm, C., Christensen, K. S., Waldemar, G., & Gasse, C. (2024) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.70014 · Cited by 2
Prevalence of insomnia and use of hypnotics in seniors from the Łodz Province, Poland
Bielec, F., Kamińska, E., Dudek, R., Koziarska-Rościszewska, M., & Rysz, J. (2019) · Family Medicine & Primary Care Review · doi:10.5114/fmpcr.2019.82973 · Cited by 2
“although non-pharmacological methods (such as behavioral therapy) are recommended for insomnia management, British doctors have pointed out their low availability and Norwegians have revealed that older patients prefer pharmacological treatment of insomnia to non-pharmacological [13, 24].”
BackgroundRussell, D. I., Reynolds, A. C., Appleton, S., Adams, R., Correia, H., Bowman, J., Gill, T. K., & Metse, A. P. (2023) · Nature and Science of Sleep · doi:10.2147/nss.s412468 · Cited by 3
“Knowledge and perceptions surrounding the efficacy of psychological treatments for insomnia may be limited.(27) Improving health professionals’ understanding and awareness of these treatments can help bridge the gap between the prevalence of insomnia and the utilisation of appropriate interventions.”
BackgroundCampbell, R. L., & Bridges, A. J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13185629 · Cited by 1
“If behavioral strategies are offered, they are typically sleep hygiene recommendations, though practitioners perceive sleep hygiene as ineffective [32], and for good reason.”
BackgroundInfluential
Metadata
- Authors
- Everitt, H., McDermott, L., Leydon, G., Yules, H., Baldwin, D., & Little, P.
- Affiliations
- King's College London (GB)
- Royal Bournemouth Hospital (GB)
- University of Southampton (GB)
- Venue
- British Journal of General Practice
- Published
- 2014-01-27
- Volume
- 64
- Issue
- 619
- Pages
- e112-e119
- ISSN
- 0960-1643 (ISSN-L)
- 1478-5242
- PMC
- PMC3905408
- OpenAlex
- W1995732384
- Cited by
- 127
- References
- 25
- Citations by year
- 2026: 4 · 2025: 16 · 2024: 13 · 2023: 10 · 2022: 11 · 2021: 20 · 2020: 15 · 2019: 15 · 2018: 7 · 2017: 3 · 2016: 7 · 2015: 5 · 2014: 1
- FWCI
- 7.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of General Practice (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Institute for Health and Care Research (CL-2006-26-002)
- University of Southampton
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- insomnia, general practitioners, management strategies, benzodiazepines, Z-drugs, amitriptyline, off-label drug use, psychotherapy, cognitive behavioral therapy for insomnia, comorbid depression and anxiety
- MeSH terms
- Amitriptyline, Antidepressive Agents, Tricyclic, Anxiety, Attitude of Health Personnel, Benzodiazepines, Depression, England, Health Expenditures, Humans, Sleep Initiation and Maintenance Disorders, Practice Patterns, Physicians', Primary Health Care, Surveys and Questionnaires, Cognitive Behavioral Therapy, Health Care Surveys, Qualitative Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.